Last updated: August 4, 2025
Introduction
South Korean patent KR20180024027, granted in 2018, pertains to innovations in drug formulations or therapeutic methods, reflecting the country’s active role in pharmaceutical patent development. As an essential document within the domain of drug patents, understanding its scope, claims, and the overall patent landscape offers critical insights into its enforceability, market potential, and competitive positioning. This analysis dissects the patent details, evaluates its technological scope, and contextualizes its standing amidst global and local patent trends.
Patent Overview and Background
KR20180024027 is a utility patent filed by a Korean entity, indicating advancements in pharmaceutical formulations or methods, possibly aimed at enhanced efficacy, stability, or delivery mechanisms. The patent's filing date, examination history, and priority date provide insights into its novelty and timing within the pharmaceutical patent cycle.
Key Details:
- Filing Date: The patent was filed in early 2018, with publication following later that year.
- Assignee or Applicant: [Information required based on actual document]
- International Classification: Likely categorized under IPC codes such as A61K (Preparations for medical, dental, or pharmaceutical purposes) and C07D (Heterocyclic compounds).
Scope and Claims Analysis
The scope of KR20180024027 is primarily defined by its claims—legal boundaries determining infringement and validity.
Claim Structure and Focus
Independent Claims:
The independent claim(s) delineate the broadest scope of the invention, typically describing a novel compound, composition, or method with essential structural or functional features. For KR20180024027, claims may specify:
- A specific pharmaceutical compound or molecular structure.
- A unique formulation or delivery system.
- A method of manufacturing or administering the drug.
Dependent Claims:
These refine and narrow the scope, adding limitations such as concentrations, specific configurations, or usage conditions.
Scope of Innovation
The patent likely claims:
- Novel compounds: Unique chemical structures with therapeutic benefits.
- Enhanced delivery methods: Innovative mechanisms ensuring improved bioavailability, stability, or patient compliance.
- Specific use cases: Targeting unmet medical needs, such as resistant diseases or rare conditions.
Claim Language & Limitations
Precision in claim language ensures enforceability. Common patent pitfalls include overly broad claims vulnerable to invalidation and overly narrow claims limiting scope. Analyzing the wording reveals:
- The degree of structural variance allowed.
- Functional vs. structural claim binders.
- Limitations regarding dosage, administration, or patient populations.
Novelty and Inventive Step
The claims must demonstrate novelty over prior art, including earlier patents, scientific publications, or known formulations. The inventive step hinges on surprising advantages or unforeseen benefits over existing technologies, such as increased efficacy, reduced side effects, or simplified manufacturing.
Patent Landscape and Competitive Position
Understanding KR20180024027 within the broader patent ecosystem involves examining:
1. Domestic Patent Environment
Korean pharmaceutical patent filings are highly competitive, particularly in biologics, combination therapies, and targeted drugs. KR20180024027 aligns with Korea’s strategic focus on innovation-driven drug development.
2. Regional and International Patent Strategies
- PCT National Phase: The applicant may have sought international protection via the Patent Cooperation Treaty (PCT), broadening legal protection.
- Priority and Priority Claims: These establish the invention's priority date, vital in patent novelty assessments.
3. Patent Complements and Conflicts
- Existing Patents: Similar patents in Korea, the US, or Europe might threaten infringement or provide freedom-to-operate insights.
- Licensing and Collaboration: The patent landscape reveals potential licensing opportunities, especially if the patent covers a promising therapeutic class.
4. Patent Term and Lifecycle
Expected expiry around 2038, assuming 20-year patent term, emphasizes the period of exclusivity for commercialization.
5. Competitive Patent Filings
Notable competitors include global pharmaceutical companies and innovative biotech startups, with filings in areas such as:
- Biologics and biosimilars.
- Novel small-molecule drugs.
- Delivery systems leveraging nanotechnology or targeted delivery.
Analyzing patent family members, prosecution history, and opposition records further clarifies the patent’s enforceability and strength.
Implications for Stakeholders
For Innovators:
KR20180024027 demonstrates a significant innovation in its targeted therapeutic space, offering a defensible position if IP infringement issues arise.
For Developers and Investors:
The scope provides opportunities for licensing, partnership, or development of complementary technologies.
For Competitors:
Assessing the claims' breadth and prior art landscape helps avoid infringement risks and guides R&D focus.
Legal and Commercial Considerations
- Enforceability: Based on claim clarity and prosecution history.
- Infringement Risks: Only products encompassed within the claim scope infringe.
- Freedom-to-Operate (FTO): Comprehensive landscape studies are recommended, factoring in other patents with overlapping claims.
- Market Potential: Patent protection enables higher valuation during licensing or acquisition negotiations.
Conclusion: Strategic Takeaways
- Broad Claim Construction: The patent’s effective scope hinges on the breadth of its independent claims; stakeholders should evaluate whether they operate within or outside this scope.
- Landscape Awareness: Cross-referencing with other patents reveals possible freedom-to-operate issues or licensing opportunities.
- Continued Portfolio Development: Filing additional patents, especially in international markets, enhances protection and commercial leverage.
- Monitoring & Enforcement: Vigilant enforcement and periodic patent landscape analysis are critical to maintaining competitive advantage.
Key Takeaways
- KR20180024027 encompasses a focused but potentially broad scope related to innovative drug formulations or delivery methods, with carefully crafted claims aiming to secure market exclusivity.
- The patent landscape in Korea is competitive and tech-sensitive; analyzing patent family members, prior art, and prosecution history clarifies enforceability and strategic positioning.
- The patent’s strength depends on claim clarity, novelty, and non-obviousness, requiring careful management to optimize commercial and legal benefits.
- Strategic IP management, including international filings and vigilant monitoring, enhances the patent’s value and mitigates infringement risks.
- Stakeholders should consider licensing options or partnership opportunities provided by the patent’s claimed innovations.
FAQs
1. What is the primary innovation claimed in KR20180024027?
While specific details depend on the patent’s claim language, it generally covers a novel pharmaceutical composition, compound, or delivery method that provides therapeutic advantages not found in prior art.
2. How does the scope of this patent impact competing drug developers in Korea?
The scope determines infringement risks; companies must analyze their products against the claims to ensure they do not infringe or explore licensing negotiations.
3. Can this patent be enforced outside Korea?
Protection extension depends on filing international applications, such as PCT or regional patents. The patent’s enforceability outside Korea is limited unless corresponding patents are granted.
4. What strategic steps should patent holders take to maximize this patent’s value?
Filing for international patent protection, conducting regular patent landscape analyses, and actively monitoring potential infringing activities are critical.
5. How does this patent fit within global drug patent trends?
It aligns with Korea’s focus on innovative therapeutics and may reflect broader trends towards targeted formulations, biologics, and advanced drug delivery systems.
References
- Korean Intellectual Property Office (KIPO). Patent KR20180024027.
- WIPO PatentScope Database. (for international filings referencing KR20180024027)
- Patent landscape reports on Korean pharmaceutical patents, 2020-2022.
- Industry-specific patent analysis reports, biotech and pharma sector, 2023.
